-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Policies and Regulations of Chemical Machinery and Equipment Network ] According to statistics, in the first half of 2021, pharmaceutical manufacturing in Jiangsu Province has increased by 49.
9%, and the pharmaceutical industry has entered a fast lane of high-quality development
.
So how will the pharmaceutical industry in Jiangsu Province develop during the 14th Five-Year Plan? Recently, Jiangsu Province issued the "14th Five-Year Plan for the Development of Pharmaceutical Industry in Jiangsu Province"
.
Chemical Machinery and Equipment Network Policies and Regulations Chemical Machinery and Equipment9%, and the pharmaceutical industry has entered a fast lane of high-quality development
.
So how will the pharmaceutical industry in Jiangsu Province develop during the 14th Five-Year Plan? Recently, Jiangsu Province issued the "14th Five-Year Plan for the Development of Pharmaceutical Industry in Jiangsu Province"
.
The plan proposes that during the "14th Five-Year Plan" period, the average annual growth rate of Jiangsu's pharmaceutical industry above designated size will be maintained at about 10%, and the proportion of innovative products in the industrial structure will continue to increase.
By 2025, Jiangsu's pharmaceutical industry will achieve industrial quality.
Efficiency, innovation ability, openness and coordination are world-class, corporate strength and industrial ecology are leading domestically, and the high-quality development level of the industry is at the forefront of the country.
It has developed into an advanced manufacturing cluster with global influence and a world-renowned innovative drug highland
.
By 2025, Jiangsu's pharmaceutical industry will achieve industrial quality.
Efficiency, innovation ability, openness and coordination are world-class, corporate strength and industrial ecology are leading domestically, and the high-quality development level of the industry is at the forefront of the country.
It has developed into an advanced manufacturing cluster with global influence and a world-renowned innovative drug highland
.
In this regard, the "Plan" determined the development direction of four key areas of biological medicine, medical equipment, chemical medicine, and traditional Chinese medicine, and specifically deployed advantageous industrial chain cultivation projects, enterprise competitiveness enhancement projects, industrial digital transformation projects, and industrial green and low-carbon development.
Seven major projects, including engineering, industrial service-oriented upgrading project, industrial opening and cooperation promotion project, and industrial safety development guarantee project
.
Seven major projects, including engineering, industrial service-oriented upgrading project, industrial opening and cooperation promotion project, and industrial safety development guarantee project
.
At the same time, the "Plan" puts forward that during the 14th Five-Year Plan period, Jiangsu Province will continue to increase R&D investment, enhance corporate innovation capabilities, deploy and build a number of service platforms such as R&D pilots, clinical trials, and safety evaluations; focus on the integration of the free trade zone and the Yangtze River Delta.
Develop opportunities, enhance openness and coordinated development, accelerate the internationalization process of the pharmaceutical industry, support the global R&D and international registration of innovative drugs; form a group of listed companies with strong resource integration and driving capabilities, cultivate a group of innovative small and medium-sized enterprises, and strengthen one Approve key enterprises in the subdivision field; further optimize the management and review mechanism in the pharmaceutical field, build a pharmaceutical industry venture capital system, develop pharmaceutical venture capital funds, and create a domestic first-class industrial development ecology
.
Develop opportunities, enhance openness and coordinated development, accelerate the internationalization process of the pharmaceutical industry, support the global R&D and international registration of innovative drugs; form a group of listed companies with strong resource integration and driving capabilities, cultivate a group of innovative small and medium-sized enterprises, and strengthen one Approve key enterprises in the subdivision field; further optimize the management and review mechanism in the pharmaceutical field, build a pharmaceutical industry venture capital system, develop pharmaceutical venture capital funds, and create a domestic first-class industrial development ecology
.
It is understood that in recent years, Jiangsu's pharmaceutical industry has shown very strong development resilience, the proportion of scale has continued to rise, and it has shown a high-quality development trend
.
In order to promote the high-quality development of the pharmaceutical industry in Jiangsu Province, Jiangsu Province has also issued a number of policy measures such as the "Opinions on Promoting the High-quality Development of the Biopharmaceutical Industry" to break through the bottleneck of biomedical technology
.
According to statistics, the province's pharmaceutical manufacturing increased by 49.
9% in the first half of 2021, and the biopharmaceutical manufacturing segment increased by 30.
5% year-on-year, and the two-year average growth rate was above 24%
.
.
In order to promote the high-quality development of the pharmaceutical industry in Jiangsu Province, Jiangsu Province has also issued a number of policy measures such as the "Opinions on Promoting the High-quality Development of the Biopharmaceutical Industry" to break through the bottleneck of biomedical technology
.
According to statistics, the province's pharmaceutical manufacturing increased by 49.
9% in the first half of 2021, and the biopharmaceutical manufacturing segment increased by 30.
5% year-on-year, and the two-year average growth rate was above 24%
.
The author has learned that Jiangsu Province has been approved for listing of new drugs, ranking first in the country for five consecutive years
.
According to statistics, as of the end of 2020, Jiangsu Province has obtained 156 product regulations for newly approved drugs for the market, accounting for 18.
48% of the 844 products in the country; 4 innovative drugs have been approved for marketing, accounting for 26.
66% of the country’s 15 domestically-made innovative drugs.
Globally, independent research and development of innovative drugs; medical device product registration stock has grown steadily, with a total of 11,764 Class II medical device registration certificates, with an increase of 1542
.
.
According to statistics, as of the end of 2020, Jiangsu Province has obtained 156 product regulations for newly approved drugs for the market, accounting for 18.
48% of the 844 products in the country; 4 innovative drugs have been approved for marketing, accounting for 26.
66% of the country’s 15 domestically-made innovative drugs.
Globally, independent research and development of innovative drugs; medical device product registration stock has grown steadily, with a total of 11,764 Class II medical device registration certificates, with an increase of 1542
.
In order to promote the rapid development of the pharmaceutical industry, Jiangsu Province actively responded
.
For example, in order to promote the implementation of the high-quality development cooperation agreement between the Provincial Market Supervision Bureau and the municipalities, and form a team with the industrial park to develop policies such as Taizhou Medical City, Suzhou Bio-Nano Park, Changzhou West Taihu Science and Technology Industrial Park, Nanjing Gaochun Medical Device Industrial Park, etc.
Preaching, assigning personnel to each other, and guiding the development of pilot projects for drug marketing license holders and medical device registrants
.
.
For example, in order to promote the implementation of the high-quality development cooperation agreement between the Provincial Market Supervision Bureau and the municipalities, and form a team with the industrial park to develop policies such as Taizhou Medical City, Suzhou Bio-Nano Park, Changzhou West Taihu Science and Technology Industrial Park, Nanjing Gaochun Medical Device Industrial Park, etc.
Preaching, assigning personnel to each other, and guiding the development of pilot projects for drug marketing license holders and medical device registrants
.
In addition, through comprehensively deepening the reform of review, approval, and opening up the "fast lane" for optimizing the business environment
.
For example, in the pilot free trade zone, the full coverage of the reform of "separation of licenses and licenses" is carried out, the construction of administrative examination and approval information is accelerated, and the in-person examination and approval is deepened.
Taking the reform of the Internet information service examination and approval of drugs and medical devices as an example, the examination and approval time has been shortened by 30 %, to further optimize the business environment and high-quality industrial development
.
.
For example, in the pilot free trade zone, the full coverage of the reform of "separation of licenses and licenses" is carried out, the construction of administrative examination and approval information is accelerated, and the in-person examination and approval is deepened.
Taking the reform of the Internet information service examination and approval of drugs and medical devices as an example, the examination and approval time has been shortened by 30 %, to further optimize the business environment and high-quality industrial development
.
In order to better promote the implementation of the "Plan" and further promote the rapid and high quality of the pharmaceutical industry, relevant persons stated that during the "14th Five-Year Plan" period, Jiangsu Province will further increase policy support, accelerate the promotion and application of innovative products, and broaden industrial financing channels.
strengthen human resources construction, create a favorable environment for development, strengthen the planning, organization and implementation
.
strengthen human resources construction, create a favorable environment for development, strengthen the planning, organization and implementation
.
Original title: Jiangsu releases the "14th Five-Year Plan" for medicine: determine four directions and deploy seven major projects
